French Innovative Leukemia Organisation

This study tests a new combination of drugs for people with Richter syndrome, an aggressive lymphoma that can develop in patients with chronic lymphocytic leukemia (CLL). The treatment adds a targeted antibody called glofitamab to standard chemotherapy. The goal is to see if this…

This study looks back at how well the drug Ivosidenib works for adults with a specific type of acute myeloid leukemia (AML) that has an IDH1 mutation. Researchers will track survival and treatment responses in 250 patients who received the drug through a compassionate use program…

This study gathers information from 50 people with a rare and aggressive blood cancer called T-cell prolymphocytic leukemia (T-PLL). Researchers will look at patients' medical records, lab results, and genetic data to better understand the disease and how it responds to current t…

This study aims to improve how doctors predict the course of Waldenstrom's macroglobulinemia, a rare blood cancer. Researchers will analyze data from 500 patients to validate existing prognostic indexes and evaluate whether progression-free survival can reliably predict overall s…